CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Pharmaceutical Technology
Original article

Charles River and MVC to develop enterovirus vaccine

PartnershipMultivalent enterovirus vaccinePositive
AI Analysis

Summary

Charles River Laboratories and MVC announced a collaboration to characterize and validate the virus seed bank for MVC's next-generation multivalent enterovirus vaccine.

Importance:5/10
Sentiment:
0.30
partnershipvaccineenteroviruscollaboration
Related Companies

Read the original article

Published by Pharmaceutical Technology on August 21, 2026 8:27 AM

Read Original